TheEdgeResearch
Home / Stocks / CSCI

COSCIENS Biopharma Inc. (CSCI)

NASDAQ Healthcare Biotechnology
$2.72 ▼ -0.00%
Market Cap
$8.6M
Sector
Healthcare
Industry
Biotechnology
Beta
1.85
52-Wk Range
1.75-4.6054
CEO
Anna Elizabeth Biehn
Country
CA
Currency
USD

COSCIENS Biopharma Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $2.72, down 0.00% on the session, giving a market capitalisation of $8.6M. On trailing twelve-month figures it carries a trailing P/E of -0.46, a net margin of -111.1%. Its beta of 1.85 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.46
Price / Sales
0.62
Price / Book
0.53
EV / EBITDA
0.41
Gross margin
49.3%
Operating margin
-132.6%
Net margin
-111.1%
Return on equity
—
Debt / equity
0.18
Current ratio
3.32
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
40
IPO date
1996-07-18
Headquarters
Toronto, ON, CA
About COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.

Comparable companies

COSCIENS Biopharma Inc. is most often compared with the following Healthcare names:

AIFUDIDAFLFCRLVROFYHGJ
More research on CSCI
CSCI technical analysis CSCI TheEdge Score Compare against peers
Open full interactive analysis & DCF →